251. Progressive supranuclear palsy with marked ventricular dilatation mimicking normal pressure hydrocephalus
- Author
-
Domenico La Torre, Alessia Sarica, Maurizio Morelli, Aldo Quattrone, Andrea Quattrone, Alessandro Mechelli, and Pier Paolo Arcuri
- Subjects
medicine.medical_specialty ,Neurology ,Automated volumetry ,Callosal angle ,Normal pressure hydrocephalus ,Progressive supranuclear palsy ,Ventricular dilatation ,medicine.diagnostic_test ,business.industry ,Magnetic resonance imaging ,Dermatology ,General Medicine ,Ventricular system ,medicine.disease ,eye diseases ,Psychiatry and Mental health ,Internal medicine ,medicine ,Cardiology ,Neurology (clinical) ,Neurosurgery ,business ,Shunt (electrical) ,Neuroradiology - Abstract
Background: Progressive supranuclear palsy (PSP) patients can show ventricular enlargement mimicking normal pressure hydrocephalus (NPH). The aim of this study was to distinguish PSP patients with marked ventricular dilatation (PSP-vd) from those with normal ventricular system and to evaluate the coexistence of NPH in PSP-vd patients. Methods: One hundred three probable PSP patients, 18 definite NPH patients, and 41 control subjects were enrolled in the study. Evans index (EI) > 0.32 associated with callosal angle (CA) < 100° was used to identify PSP-vd patients. Automated ventricular volumetry (AVV) and Magnetic Resonance Hydrocephalic Index (MRHI) were performed on T1-weighted MR images to evaluate the presence of NPH in PSP-vd patients. Results: Twelve (11.6%) out of 103 PSP patients had both abnormal EI and CA values (PSP-vd). In two of these 12 patients, AVV and MRHI values suggested PSP + NPH. In the remaining 10 PSP-vd patients, AVV and MRHI values were higher than PSP patients with normal ventricular system and controls, but lower than PSP + NPH and NPH patients, suggesting a non-hydrocephalic ventricular enlargement. Discussion: Our study provides evidence that the combination of EI and CA biomarkers allowed to identify PSP patients with marked ventricular dilatation mimicking NPH. Only a few of these patients had PSP + NPH. Recognition of these PSP patients with enlarged ventricles can positively impact the care of this disease, helping clinicians to identify patients with PSP + NPH who could benefit from shunt procedure and avoid surgery in those with enlarged ventricles without NPH.
- Published
- 2022
- Full Text
- View/download PDF